{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:23:04Z","timestamp":1787894584094,"version":"build-2784847793"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Early identification and treatment of attention-deficit\/hyperactivity disorder (ADHD) symptoms in preschool-age children is important for mitigating social, emotional, and academic problems. Clinical practice guidelines recommend first-line behavior intervention before considering medication treatment for children aged 4 to 5 years.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess variation in rates of ADHD identification and rates and timing of medication initiation in children aged 3 to 5 years in primary care settings across 8 US pediatric health systems and to identify patient factors associated with the time from diagnosis to prescription.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study used electronic health records from primary care clinics affiliated with 8 academic institutions participating in the PEDSnet Clinical Research Network. Participants were children aged 3 to 5 years seen between 2016 to 2023. Data were extracted from the PEDSnet database on April 18, 2025.<\/jats:p><\/jats:sec>Exposure<\/jats:title>ADHD diagnosis at age 4 to 5 years.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcomes were (1) rate of ADHD diagnosis, (2) rate of stimulant and nonstimulant prescription after diagnosis before age 7 years, and (3) time from first ADHD-related diagnosis (including symptom-level diagnoses) to medication prescription. Independent variables included institution, year of diagnosis, patient age, sex, race and ethnicity, medical insurance, and presence of comorbidities. Multivariable Cox proportional hazards models were used to estimate associations between clinical and demographic variables and time from diagnosis to prescription.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 712\u202f478 children seen in primary care at age 3 to 5 years, 9708 (1.4%) received an ADHD diagnosis at age 4 to 5 years (range across institutions, 0.5%-3.1%; median [IQR] age at first ADHD-related diagnosis, 5.31 [4.86-5.66] years). Of those with ADHD, 7414 (76.4%) were male, 1762 (18.1%) were Hispanic, 122 (1.3%) were non-Hispanic Asian, 3014 (31.0%) were non-Hispanic Black, 479 (4.9%) were non-Hispanic multiracial, 3782 (39.0%) were non-Hispanic White, 148 (1.5%) were non-Hispanic other, and 401 (4.1%) were of unknown race and ethnicity. Of 9708 preschool-age children with ADHD, 6624 (68.2%) were prescribed ADHD medications before age 7 years, and 4092 (42.2%) were prescribed medications within 30 days of the first documentation of an ADHD-related diagnosis (range across institutions, 26.0%-49.0%). Asian (adjusted hazard ratio [aHR], 0.51; 95% CI, 0.38-0.68), Hispanic (aHR, 0.75; 95% CI, 0.70-0.81), and Black (aHR, 0.88; 95% CI, 0.83-0.94) children with ADHD were less likely to be prescribed medication early compared with White children. Older vs younger patients (aHR, 1.62; 95% CI, 1.55-1.69), male vs female patients (aHR, 1.17; 95% CI, 1.11-1.25), and publicly insured vs privately insured patients (aHR, 1.09; 95% CI, 1.03-1.15) were more likely to be prescribed medication early.<\/jats:p><\/jats:sec>Conclusion and Relevance<\/jats:title>In this retrospective cohort study of preschool-age children with ADHD seen in primary care in 8 large pediatric health systems, many children were prescribed medications at or shortly after the first documented diagnosis. Analysis of clinical documentation is needed to understand early prescription patterns.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.29610","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:30:35Z","timestamp":1756481435000},"page":"e2529610","source":"Crossref","is-referenced-by-count":6,"title":["ADHD Diagnosis and Timing of Medication Initiation Among Children Aged 3 to 5 Years"],"prefix":"10.1001","volume":"8","author":[{"given":"Yair","family":"Bannett","sequence":"first","affiliation":[{"name":"Division of Developmental-Behavioral Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Luo","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Azuero-Dajud","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Division of Developmental-Behavioral Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah W.","family":"Brink","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nationwide Children\u2019s Hospital, The Ohio State University College of Medicine, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya E.","family":"Froehlich","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly K.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Texas Children\u2019s Hospital, Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E.","family":"Wallis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Division of Developmental and Behavioral Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Whelan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Spector","sequence":"additional","affiliation":[{"name":"Division of Developmental and Behavioral Pediatrics, Nemours Children\u2019s Hospital, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"10","key":"zoi250834r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.36872","article-title":"Prevalence and trends in diagnosed ADHD among US children and adolescents, 2017-2022.","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250834r2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15374416.2024.2335625","article-title":"ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment.","volume":"53","author":"Danielson","year":"2024","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"2","key":"zoi250834r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0038","article-title":"School readiness in preschoolers with symptoms of attention-deficit\/hyperactivity disorder.","volume":"144","author":"Perrin","year":"2019","journal-title":"Pediatrics"},{"issue":"7","key":"zoi250834r4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1469-7610.2005.01466.x","article-title":"The impact of preschool inattention, hyperactivity, and impulsivity on social and academic development: a review.","volume":"46","author":"Spira","year":"2005","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"zoi250834r5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1542\/peds.2011-2654","article-title":"ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents.","volume":"128","author":"Wolraich","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"zoi250834r6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2528","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents.","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250834r7","doi-asserted-by":"publisher","first-page":"e1584","DOI":"10.1542\/peds.2012-0974","article-title":"Interventions for preschool children at high risk for ADHD: a comparative effectiveness review.","volume":"131","author":"Charach","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"zoi250834r8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.jpeds.2015.02.018","article-title":"Treatment of attention deficit\/hyperactivity disorder among children with special health care needs.","volume":"166","author":"Visser","year":"2015","journal-title":"J Pediatr"},{"issue":"269","key":"zoi250834r9","first-page":"1","article-title":"Physician office visits for attention-deficit\/hyperactivity disorder in children and adolescents aged 4-17 years: United States, 2012-2013.","author":"Albert","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"7","key":"zoi250834r10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1089\/cap.2020.0015","article-title":"Epidemiology of treatment for preschoolers on Kentucky Medicaid diagnosed with attention-deficit\/hyperactivity disorder.","volume":"30","author":"Davis","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"zoi250834r11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.acap.2019.11.016","article-title":"Attention-deficit\/hyperactivity disorder in 2- to 5-year-olds: a primary care network experience.","volume":"21","author":"Bannett","year":"2021","journal-title":"Acad Pediatr"},{"issue":"7","key":"zoi250834r12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/DBP.0000000000000477","article-title":"A national profile of attention-deficit hyperactivity disorder diagnosis and treatment among US children aged 2 to 5 years.","volume":"38","author":"Danielson","year":"2017","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"zoi250834r13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2832","article-title":"Attention-deficit\/hyperactivity disorder and psychotropic polypharmacy prescribing trends.","volume":"146","author":"Girand","year":"2020","journal-title":"Pediatrics"},{"issue":"6","key":"zoi250834r14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2025","article-title":"Preschool ADHD diagnosis and stimulant use before and after the 2011 AAP Practice Guideline.","volume":"138","author":"Fiks","year":"2016","journal-title":"Pediatrics"},{"issue":"13","key":"zoi250834r15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.15585\/mmwr.mm7213a1","article-title":"Trends in stimulant prescription fills among commercially insured children and adults\u2014United States, 2016-2021.","volume":"72","author":"Danielson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"zoi250834r16","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents, United States, 1999-2014.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"17","key":"zoi250834r17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.15585\/mmwr.mm6517e1","article-title":"Vital signs: national and state-specific patterns of attention deficit\/hyperactivity disorder treatment among insured children aged 2-5 years\u2014United States, 2008-2014.","volume":"65","author":"Visser","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi250834r18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jpeds.2019.06.025","article-title":"Factors associated with attention deficit hyperactivity disorder medication use in community care settings.","volume":"213","author":"Kamimura-Nishimura","year":"2019","journal-title":"J Pediatr"},{"issue":"3","key":"zoi250834r19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.acap.2017.10.003","article-title":"Receipt of medication and behavioral therapy among a national sample of school-age children diagnosed with attention-deficit\/hyperactivity disorder.","volume":"18","author":"Walls","year":"2018","journal-title":"Acad Pediatr"},{"issue":"3","key":"zoi250834r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0321","article-title":"Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort.","volume":"4","author":"Shi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi250834r21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.acap.2021.01.020","article-title":"Toward equitable health outcomes for diverse children with ADHD and their families.","volume":"21","author":"Lindly","year":"2021","journal-title":"Acad Pediatr"},{"issue":"3","key":"zoi250834r22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0407","article-title":"Racial and ethnic disparities in ADHD diagnosis and treatment.","volume":"138","author":"Coker","year":"2016","journal-title":"Pediatrics"},{"issue":"10","key":"zoi250834r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"13","key":"zoi250834r24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1177\/10870547221099961","article-title":"State-level estimates of the prevalence of parent-reported ADHD diagnosis and treatment among U.S. children and adolescents, 2016 to 2019.","volume":"26","author":"Danielson","year":"2022","journal-title":"J Atten Disord"},{"issue":"2","key":"zoi250834r25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/DBP.0000000000000626","article-title":"The association between race\/ethnicity and socioeconomic factors and the diagnosis and treatment of children with attention-deficit hyperactivity disorder.","volume":"40","author":"Bax","year":"2019","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"zoi250834r26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/DBP.0000000000000585","article-title":"Common use of stimulants and alpha-2 agonists to treat preschool attention-deficit hyperactivity disorder: a DBPNet study.","volume":"39","author":"Blum","year":"2018","journal-title":"J Dev Behav Pediatr"},{"key":"zoi250834r27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jpeds.2017.08.040","article-title":"A national description of treatment among United States Children and adolescents with attention-deficit\/hyperactivity disorder.","volume":"192","author":"Danielson","year":"2018","journal-title":"J Pediatr"},{"issue":"1","key":"zoi250834r28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/jamapediatrics.2021.4093","article-title":"Rate of pediatrician recommendations for behavioral treatment for preschoolers with attention-deficit\/hyperactivity disorder diagnosis or related symptoms.","volume":"176","author":"Bannett","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"6","key":"zoi250834r29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.acap.2023.03.014","article-title":"Understanding barriers and facilitators of attention-deficit\/hyperactivity disorder treatment initiation and adherence in Black and Latinx children.","volume":"23","author":"Kamimura-Nishimura","year":"2023","journal-title":"Acad Pediatr"},{"issue":"2","key":"zoi250834r30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10567-021-00368-y","article-title":"A review of predictors of psychosocial service utilization in youth with attention-deficit\/hyperactivity disorder.","volume":"25","author":"Green","year":"2022","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"2","key":"zoi250834r31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2013.2862","article-title":"Acceptance of insurance by psychiatrists and the implications for access to mental health care.","volume":"71","author":"Bishop","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"20","key":"zoi250834r32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1001\/jama.2021.6118","article-title":"a2-Adrenergic agonists or stimulants for preschool-age children with attention-deficit\/hyperactivity disorder.","volume":"325","author":"Harstad","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"zoi250834r33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jaac.2017.03.014","article-title":"Specific components of pediatricians\u2019 medication-related care predict attention-deficit\/hyperactivity disorder symptom improvement.","volume":"56","author":"Epstein","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"zoi250834r34","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/jamia\/ocae001","article-title":"Measuring quality-of-care in treatment of young children with attention-deficit\/hyperactivity disorder using pre-trained language models.","volume":"31","author":"Pillai","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"zoi250834r35","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1542\/hpeds.2024-008115","article-title":"Natural language processing: set to transform pediatric research.","volume":"15","author":"Bannett","year":"2025","journal-title":"Hosp Pediatr"},{"issue":"1","key":"zoi250834r36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067223","article-title":"Applying large language models to assess quality of care: monitoring ADHD medication side effects.","volume":"155","author":"Bannett","year":"2025","journal-title":"Pediatrics"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2838257\/bannett_2025_oi_250834_1755882726.75343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:30:36Z","timestamp":1756481436000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2838257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.29610","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}